Pharmacist Suspended for 12 Months Over Governance Failures at Cannabis-Based Medicines Pharmacy
Date of Decision: March 3, 2025
Registrant's Role: Pharmacist
Allegations:
- Failure to implement adequate governance and safeguarding procedures at a pharmacy dispensing Cannabis-Based Medicinal Products (CBMPs).
- Operating without a Responsible Pharmacist (RP) on duty on multiple occasions.
- Poor Controlled Drug (CD) management, including incomplete or missing records.
- Allowing an unqualified company director to manage pharmacy operations.
- Failure to store Schedule 2 Controlled Drugs appropriately.
Outcome: Registrant 1: Suspended from the GPhC register for 12 months (with review); Registrant 2: Issued with a formal warning.
GPhC Standards Breached:
- Standard 2 – Work in partnership with others
- Standard 5 – Use professional judgment
- Standard 6 – Behave in a professional manner
- Standard 9 – Demonstrate leadership
Case Summary
The General Pharmaceutical Council (GPhC) investigated two registrants following serious governance failures at Cannabliss Pharmacy, which specialized in dispensing Cannabis-Based Medicinal Products (CBMPs).
Between February 2021 and May 2022, the pharmacy:
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.